´ëÇѹæ»ç¼±Á¾¾çÇÐȸ 2022³â 4Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2022-10-14±³À°ÀÏÀÚ : 2022-10-14
±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ(¼Ò°øµ¿)
±³À°ÁÖÁ¦ :
2022³â 4Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ
´ã´çÀÚ : ÃÖÇýÁø
¿¬¶ôó : 02-743-6574
À̸ÞÀÏ :
kosro@kosro.or.kr ±³À°Á¾·ù : ¹æ»ç¼±Á¾¾çÇаú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í ¿ø·Îȸ¿ø:¹«·á Á¤È¸¿ø(Àü¹®ÀÇ) : 80,000¿ø ¼ö·Ãȸ¿ø : 50,000¿ø Ưº°È¸¿ø(ÀÇÇй°¸®/»ý¹°¹Ú»ç) : 50,000¿ø ÁØȸ¿ø : 30,000¿ø ºñȸ¿ø : 120,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-14 ·Ôµ¥È£ÅÚ 08:20~09:10 Recent Trends of the National Quality Assessment of Lung Cancer Management in South Korea during 2013 – 2016 À̽ÿø(ÀºÆò¼º¸ðº´¿ø)
±³À°½Ã°£ 10-14 ·Ôµ¥È£ÅÚ 09:10~10:00 Comparison of stereotactic body radiation therapy and lobectomy in clinical stage I non-small cell lung cancer À̽ÃÈ£(¾ÆÁִ뺴¿ø)
±³À°½Ã°£ 10-14 ·Ôµ¥È£ÅÚ 10:20~11:10 Tumor Microbiome Dynamics in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy ÀÌÇýÀÎ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-14 ·Ôµ¥È£ÅÚ 11:10~12:00 Liver-directed combined radiotherapy for downstaging of over the Milan advanced hepatocellular carcinoma converting to liver transplantation ±è¿ëÅÂ(¿¬¼¼¾Ïº´¿ø)
½Ä»ç 10-14 ·Ôµ¥È£ÅÚ 12:00~13:00 ·±Ãµ ()
±³À°½Ã°£ 10-14 ·Ôµ¥È£ÅÚ 13:00~13:40 The K-MASTER project ±è¿È«(°í·Á´ëÇб³)
±³À°½Ã°£ 10-14 ·Ôµ¥È£ÅÚ 13:40~14:10 No axillary surgical treatment in clinically lymph node negative patients after ultrasonography [NAUTILUS trial] ÇÑ¿ø½Ä(¼¿ï´ëÇб³)
±³À°½Ã°£ 10-14 ·Ôµ¥È£ÅÚ 14:10~14:40 Rectal cancer: TV-LARK trial ÁöÀDZÔ(¼¿ï´ëÇб³)
ÈÞ½Ä 10-14 ·Ôµ¥È£ÅÚ 14:40~15:00 ÈÞ½Ä ()
±³À°½Ã°£ 10-14 ·Ôµ¥È£ÅÚ 15:00~16:15 FLASH Therapy, Disruptive Innovation in Radiotherapy Àå¿øÀÏ(Çѱ¹¿øÀÚ·ÂÀÇÇпø)
±³À°½Ã°£ 10-14 ·Ôµ¥È£ÅÚ 16:15~17:30 Response Assessment in Brain Metastases: A Gentle Guide for Radiation Oncologists into RANO, iRANO, and LANO ¹Ú¿¹¿ø(½ÅÃ̼¼ºê¶õ½ºº´¿ø)